Behavioral interventions for tobacco use in HIV-infected smokers: A meta-analysis

Asheena Keith, Yuelei Dong, Jonathan Shuter, Seth Himelhoch

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers. Objective: To assess the efficacy of behavioral interventions for smoking cessation among HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane, CINHAL, PsychINFO, and Google Scholar were searched for randomized controlled trials published in English. Study selection: Eligibility criteria were randomized controlled trials with targeted behavioral interventions compared with standard of care (or enhanced standard of care) aimed at promoting abstinence in HIV-infected smokers. A total of 17,384 articles were found and 17,371 were excluded; 13 full text articles were obtained and reviewed, and 8 met the eligibility criteria (Κ 0.94). Data extraction: The primary outcome was expired carbon monoxide-verified 7-day point prevalence abstinence rates. Adequate sequence generation and freedom from incomplete or selective outcome reporting was used to assess study quality. Results: A total of 1822 subjects from 8 studies yielded a statistically significant effect of behavioral interventions in increasing abstinence in HIV-infected smokers with a moderate effect size (relative risk: 1.51; 95% confidence interval: 1.17 to 1.95). Those studies with interventions of 8 sessions or more had a large effect size for abstinence (relative risk: 2.88; 95% confidence interval: 1.89 to 4.61). When stratified by the number of sessions, there was no heterogeneity. Conclusions: Targeted behavioral smoking cessation interventions are efficacious. Interventions consisting of 8 sessions or more had the greatest treatment efficacy.

Original languageEnglish (US)
Pages (from-to)527-533
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume72
Issue number5
DOIs
StatePublished - Aug 15 2016

Fingerprint

Tobacco Use
Meta-Analysis
HIV
Smoking Cessation
Standard of Care
Randomized Controlled Trials
Confidence Intervals
Information Storage and Retrieval
Carbon Monoxide
PubMed
Patient Selection
Smoking
Morbidity
Mortality

Keywords

  • behavioral interventions
  • HIV smokers
  • targeted smoking cessation interventions

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Behavioral interventions for tobacco use in HIV-infected smokers : A meta-analysis. / Keith, Asheena; Dong, Yuelei; Shuter, Jonathan; Himelhoch, Seth.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 72, No. 5, 15.08.2016, p. 527-533.

Research output: Contribution to journalArticle

@article{c0855a13554a4df2972e4877d19b0ebb,
title = "Behavioral interventions for tobacco use in HIV-infected smokers: A meta-analysis",
abstract = "Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers. Objective: To assess the efficacy of behavioral interventions for smoking cessation among HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane, CINHAL, PsychINFO, and Google Scholar were searched for randomized controlled trials published in English. Study selection: Eligibility criteria were randomized controlled trials with targeted behavioral interventions compared with standard of care (or enhanced standard of care) aimed at promoting abstinence in HIV-infected smokers. A total of 17,384 articles were found and 17,371 were excluded; 13 full text articles were obtained and reviewed, and 8 met the eligibility criteria (Κ 0.94). Data extraction: The primary outcome was expired carbon monoxide-verified 7-day point prevalence abstinence rates. Adequate sequence generation and freedom from incomplete or selective outcome reporting was used to assess study quality. Results: A total of 1822 subjects from 8 studies yielded a statistically significant effect of behavioral interventions in increasing abstinence in HIV-infected smokers with a moderate effect size (relative risk: 1.51; 95{\%} confidence interval: 1.17 to 1.95). Those studies with interventions of 8 sessions or more had a large effect size for abstinence (relative risk: 2.88; 95{\%} confidence interval: 1.89 to 4.61). When stratified by the number of sessions, there was no heterogeneity. Conclusions: Targeted behavioral smoking cessation interventions are efficacious. Interventions consisting of 8 sessions or more had the greatest treatment efficacy.",
keywords = "behavioral interventions, HIV smokers, targeted smoking cessation interventions",
author = "Asheena Keith and Yuelei Dong and Jonathan Shuter and Seth Himelhoch",
year = "2016",
month = "8",
day = "15",
doi = "10.1097/QAI.0000000000001007",
language = "English (US)",
volume = "72",
pages = "527--533",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Behavioral interventions for tobacco use in HIV-infected smokers

T2 - A meta-analysis

AU - Keith, Asheena

AU - Dong, Yuelei

AU - Shuter, Jonathan

AU - Himelhoch, Seth

PY - 2016/8/15

Y1 - 2016/8/15

N2 - Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers. Objective: To assess the efficacy of behavioral interventions for smoking cessation among HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane, CINHAL, PsychINFO, and Google Scholar were searched for randomized controlled trials published in English. Study selection: Eligibility criteria were randomized controlled trials with targeted behavioral interventions compared with standard of care (or enhanced standard of care) aimed at promoting abstinence in HIV-infected smokers. A total of 17,384 articles were found and 17,371 were excluded; 13 full text articles were obtained and reviewed, and 8 met the eligibility criteria (Κ 0.94). Data extraction: The primary outcome was expired carbon monoxide-verified 7-day point prevalence abstinence rates. Adequate sequence generation and freedom from incomplete or selective outcome reporting was used to assess study quality. Results: A total of 1822 subjects from 8 studies yielded a statistically significant effect of behavioral interventions in increasing abstinence in HIV-infected smokers with a moderate effect size (relative risk: 1.51; 95% confidence interval: 1.17 to 1.95). Those studies with interventions of 8 sessions or more had a large effect size for abstinence (relative risk: 2.88; 95% confidence interval: 1.89 to 4.61). When stratified by the number of sessions, there was no heterogeneity. Conclusions: Targeted behavioral smoking cessation interventions are efficacious. Interventions consisting of 8 sessions or more had the greatest treatment efficacy.

AB - Context: Smoking is responsible for increased morbidity and mortality in HIV-infected smokers. Objective: To assess the efficacy of behavioral interventions for smoking cessation among HIV-infected smokers compared with the standard care. Data sources: PubMed, Cochrane, CINHAL, PsychINFO, and Google Scholar were searched for randomized controlled trials published in English. Study selection: Eligibility criteria were randomized controlled trials with targeted behavioral interventions compared with standard of care (or enhanced standard of care) aimed at promoting abstinence in HIV-infected smokers. A total of 17,384 articles were found and 17,371 were excluded; 13 full text articles were obtained and reviewed, and 8 met the eligibility criteria (Κ 0.94). Data extraction: The primary outcome was expired carbon monoxide-verified 7-day point prevalence abstinence rates. Adequate sequence generation and freedom from incomplete or selective outcome reporting was used to assess study quality. Results: A total of 1822 subjects from 8 studies yielded a statistically significant effect of behavioral interventions in increasing abstinence in HIV-infected smokers with a moderate effect size (relative risk: 1.51; 95% confidence interval: 1.17 to 1.95). Those studies with interventions of 8 sessions or more had a large effect size for abstinence (relative risk: 2.88; 95% confidence interval: 1.89 to 4.61). When stratified by the number of sessions, there was no heterogeneity. Conclusions: Targeted behavioral smoking cessation interventions are efficacious. Interventions consisting of 8 sessions or more had the greatest treatment efficacy.

KW - behavioral interventions

KW - HIV smokers

KW - targeted smoking cessation interventions

UR - http://www.scopus.com/inward/record.url?scp=84961888058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961888058&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000001007

DO - 10.1097/QAI.0000000000001007

M3 - Article

C2 - 27028502

AN - SCOPUS:84961888058

VL - 72

SP - 527

EP - 533

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -